CJC-1295 With DAC 2 mg
A proposed long-acting GHRH-analogue product; sequence and conjugate require confirmation.
CAD $60.00 / vial
Vial amount
The specifics, clearly listed.
Product details
Product reference: MRD-0041 Listed amount per vial: 2 mg Sales unit: 1 vial
Read the research in context.
A proposed long-acting GHRH-analogue product; sequence and conjugate require confirmation.
- Prolonged stimulation of growth hormone (GH) and insulin-like growth factor I secretion by CJC-1295, a long-acting analog of GH-releasing hormone, in healthy adults — source
- Pulsatile secretion of growth hormone (GH) persists during continuous stimulation by CJC-1295, a long-acting GH-releasing hormone analog — source
Candidate-molecule or reference-product background; not verification of this supplied product.
What this doesn’t establish: Exact sequence, DAC linker, attachment site, salt and impurities must be confirmed. Preserve a separate family from no-DAC products. Exact supplied identity/form, measured amount, lot-linked quality reports, purity, sterility/endotoxin, storage/stability and authorization are not established by these references.
Product documents
No verified report is available here for this item. Ask about documentation for CJC-1295 With DAC, product reference MRD-0041.
Before you decide.
Separate research about the compound from evidence about the supplied product.
Which vial amount is shown?
This listing shows 2 mg per vial.
Does the study verify this vial?
No. Research on a compound does not establish the identity, quality, safety or effectiveness of a product sold under that name.
What should I check in a report?
Check the sample identity, batch reference, issuer, date, test methods and results. A report applies to the identified sample and tests.
What information should I request?
Ask about the exact product identity, form, specification, handling requirements and relevant batch documents before deciding.